Multicenter Phase II Trial of YM155, a Small-Molecule Suppressor of Survivin, in Patients With Advanced, Refractory, Non-Small-Cell Lung Cancer

G. Giaccone, P. Zatloukal, J. Roubec, K. Floor, J. Musil, M. Kuta, R.J. van Klaveren, S. Chaudhary, A. Gunther, S. Shamsili

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)4481-4486
JournalJournal of Clinical Oncology
Issue number27
Publication statusPublished - 2009

Cite this